— Latest update: March 2025 —
Japan is a major player in bioinformatics, a sector that is currently worth approximately 16 billion dollars globally. The country, after China, is the second largest bioinformatics market in Asia, which itself is this field’s fastest growing region. In particular, Japan poses unique challenges due to its urgent need to address the growing health concerns of an aging population, while the country’s existing digitalisation efforts provide opportunities for innovation. Furthermore, with Asia’s largest bioinformatics database located in Japan, the sector will be of an increasing importance, especially with its application to the medical and pharmaceutical industries.
METI, Survey on Trends in Critical and Emerging Developments in Biotechnology, 2023
EU-Japan Centre, Latest trends in biotechnology research in Japan, 2021
Table of Contents
The EU-Japan Centre currently produces 5 newsletters :
You are now accessing a members only part of our website available to EU companies only.
Please create an account (or login) to access information, reports and webinars about Japan.